Regulatory

Biosimilars image supplied by Allied Market Research
News
|

Report examines biosimilars market drivers

Manufacturers see opportunity as blockbuster biologics face patent expiries, with emerging markets representing an easier ‘launching pad’ for biosimilars/follow-on biologics.
E-Book Special Report
Total Cost of Ownership
Sign up to receive timely updates from our editors and download this E-Book Special Report to learn how to calculate the true Total Cost of Ownership (TCO) of your packaging machinery.
Wendy Buckley, President and Founder of Specialty Transportation and Regulatory Services
Column/Opinion
|

HM-251—It’s not just for crude oil anymore

Just a few months after HM-251 was published, there are already multiple appeals and at least two lawsuits.
Eric Greenberg
Column/Opinion
|

Animal product regulation is a complex creature

When it comes to keeping track of regulatory requirements, sometimes it seems like it’s raining cats and dogs. And cows and chickens.
Credo production line.
Column/Opinion
|

Three primary cold chain packaging pain points and priorities

Along with preventing temperature excursions, three priority issues are regulatory compliance, reducing costs, and emerging markets.
Eric Greenberg
Column/Opinion
|

Trim the fat, cut the GRAS?

Use it or lose it, goes the old saying. But what happens if you do use it? Why, it makes you want to use it again, of course.
FDA revises proposed Nutrition Facts label rule
News
|

FDA revises proposed Nutrition Facts label rule

Aim is to include a daily value for added sugars to help consumers make more informed choices. Public comments welcomed for 75 days from July 24, 2015.
Eric Greenberg
Column/Opinion
|

Pot marketers eating up opportunities, shaping regulation

The swift emergence of legal marijuana, for medical or merely recreational use, continues to be a story of fascinating challenges.
What market is forecast to top $80 billion by 2020?
News
|

What market is forecast to top $80 billion by 2020?

E-pedigree authentication, holograms to grow the pharmaceutical and cosmetics anti-counterfeiting technology market.
This photo shows capsules with a DNA imprinted on them.
Feature Article
|

What’s new in personalized medicine?

A new PwC/Personalized Medicine Initiative Green Paper describes patient benefits. Meanwhile, Grand View Research predicts the global genomics market value to top US$22 billion by 2020.
Eric Greenberg
Column/Opinion
|

GMO foods and labels: many angles, many squabbles

The ongoing debates about genetically modified organisms in food, especially over label statements saying a food lacks GMOs, seem to be everywhere all at once.

Pages

Subscribe to Regulatory

Newsletters

Don't miss intelligence crucial to your job and business!
Click on any newsletter to view a sample. Enter your email address below to sign up!
GENERAL INTEREST
PACKAGE DESIGN/DEVELOPMENT
PACKAGING MACHINERY
SPECIAL INTEREST
PACK EXPO
Each newsletter ranges in frequency from once per month to a few times per month at most.